FDA expands Sanofi’s type 1 diabetes injection to newly diagnosed stage 3 kids
A Friday FDA decision greenlights use for children ages 8 to 17, shifting treatment access and competitive pressure.
By Mohammed Al-Shehri·· 3 min
1 briefing · “sanofi”
A Friday FDA decision greenlights use for children ages 8 to 17, shifting treatment access and competitive pressure.